US BNP And NTproBNP Market Size study, by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Others), by Location of Testing (Point of Care Testing, Laboratory Testing) Forecasts 2022-2032
US BNP And NTproBNP Market is valued at approximately USD 273.69 million in 2023 and is anticipated to grow with a healthy growth rate of more than 2.32% over the forecast period 2024-2032. BNP (B-type Natriuretic Peptide) and NT-proBNP (the N-terminal prohormone of BNP) are hormones released by the heart in response to increased pressure and volume, common in heart failure. Elevated levels of these biomarkers indicate heart stress and help differentiate cardiac-related symptoms like shortness of breath from other causes. In clinical practice, measuring BNP And NTproBNP guides treatment choices, predicts patient outcomes, and assesses heart failure severity. Regular monitoring is crucial for adjusting treatments and managing heart failure effectively, improving patient care and outcomes. These biomarkers play a pivotal role in modern cardiology, enabling healthcare providers to tailor therapies and interventions to meet the specific needs of heart failure patients. The US BNP And NTproBNP market is the increasing emphasis on early detection and treatment of heart failure, correlating with the rising incidence of cardiovascular disorders. This trend is bolstered by advancements in diagnostic technology and the aging population. Furthermore, increasing healthcare spending and the development of healthcare infrastructure in emerging regions contribute to market expansion.
The US BNP And NTproBNP market is driven by the high incidence of cardiovascular diseases underscores the need for early and accurate diagnostic methods. Advanced healthcare infrastructure facilitates widespread use of these biomarkers in clinical settings. Increased healthcare expenditure supports access to state-of-the-art diagnostic technologies. Significant investment in research and development drives ongoing innovation in diagnostic tools. Rising awareness among healthcare providers and patients about the importance of early detection and treatment of heart failure continues to drive market demand. Moreover, favorable reimbursement policies and government initiatives aimed at enhancing cardiac care further bolster market expansion in the US. However, the high cost of these diagnostic tests, limits their accessibility for some patient populations. Reimbursement challenges and varying insurance coverage can deter widespread adoption.
Major market player included in this report are:
Danaher Corporation
Quidel Corporation
PerkinElmer Inc.
Scripps Laboratories
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome (ACS)
Others
By Location of Testing
Point of Care Testing
Laboratory Testing
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
The US BNP And NTproBNP market is driven by the high incidence of cardiovascular diseases underscores the need for early and accurate diagnostic methods. Advanced healthcare infrastructure facilitates widespread use of these biomarkers in clinical settings. Increased healthcare expenditure supports access to state-of-the-art diagnostic technologies. Significant investment in research and development drives ongoing innovation in diagnostic tools. Rising awareness among healthcare providers and patients about the importance of early detection and treatment of heart failure continues to drive market demand. Moreover, favorable reimbursement policies and government initiatives aimed at enhancing cardiac care further bolster market expansion in the US. However, the high cost of these diagnostic tests, limits their accessibility for some patient populations. Reimbursement challenges and varying insurance coverage can deter widespread adoption.
Major market player included in this report are:
Danaher Corporation
Quidel Corporation
PerkinElmer Inc.
Scripps Laboratories
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome (ACS)
Others
By Location of Testing
Point of Care Testing
Laboratory Testing
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
CHAPTER 1. US BNP AND NTPROBNP MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US BNP And NTproBNP Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Application
2.2.2. By Location of Testing
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US BNP AND NTPROBNP MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US BNP AND NTPROBNP MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US BNP AND NTPROBNP MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
5.1. Myocardial Infarction
5.2. Congestive Heart Failure
5.3. Acute Coronary Syndrome (ACS)
5.4. Others
CHAPTER 6. US BNP AND NTPROBNP MARKET SIZE & FORECASTS BY LOCATION OF TESTING 2022-2032
6.1. Point of Care Testing
6.2. Laboratory Testing
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Danaher Corporation
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Quidel Corporation
7.3.3. PerkinElmer Inc.
7.3.4. Scripps Laboratories
7.3.5. Abbott Laboratories
7.3.6. Bio-Rad Laboratories, Inc.
7.3.7. Company
7.3.8. Company
7.3.9. Company
7.3.10. Company
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US BNP And NTproBNP Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Application
2.2.2. By Location of Testing
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US BNP AND NTPROBNP MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US BNP AND NTPROBNP MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US BNP AND NTPROBNP MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
5.1. Myocardial Infarction
5.2. Congestive Heart Failure
5.3. Acute Coronary Syndrome (ACS)
5.4. Others
CHAPTER 6. US BNP AND NTPROBNP MARKET SIZE & FORECASTS BY LOCATION OF TESTING 2022-2032
6.1. Point of Care Testing
6.2. Laboratory Testing
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Danaher Corporation
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Quidel Corporation
7.3.3. PerkinElmer Inc.
7.3.4. Scripps Laboratories
7.3.5. Abbott Laboratories
7.3.6. Bio-Rad Laboratories, Inc.
7.3.7. Company
7.3.8. Company
7.3.9. Company
7.3.10. Company
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
LIST OF TABLES
TABLE 1. US BNP And NTproBNP market, report scope
TABLE 2. US BNP And NTproBNP market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 3. US BNP And NTproBNP market estimates & forecasts by Location of Testing 2022-2032 (USD Million)
TABLE 4. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 5. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. U.S. BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 11. U.S. BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. List of secondary sources, used in the study of US BNP And NTproBNP Market.
TABLE 13. List of primary sources, used in the study of US BNP And NTproBNP Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered
TABLE 1. US BNP And NTproBNP market, report scope
TABLE 2. US BNP And NTproBNP market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 3. US BNP And NTproBNP market estimates & forecasts by Location of Testing 2022-2032 (USD Million)
TABLE 4. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 5. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. US BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. U.S. BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. U.S. BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 11. U.S. BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 12. List of secondary sources, used in the study of US BNP And NTproBNP Market.
TABLE 13. List of primary sources, used in the study of US BNP And NTproBNP Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered
LIST OF FIGURES
FIG 1. US BNP And NTproBNP market, research methodology
FIG 2. US BNP And NTproBNP market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US BNP And NTproBNP market, key trends 2023
FIG 5. US BNP And NTproBNP market, growth prospects 2022-2032
FIG 6. US BNP And NTproBNP market, porters 5 force model
FIG 7. US BNP And NTproBNP market, pestel analysis
FIG 8. US BNP And NTproBNP market, value chain analysis
FIG 9. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 10. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 11. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 12. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 13. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 14. US BNP And NTproBNP market, company market share analysis (2023)
FIG 1. US BNP And NTproBNP market, research methodology
FIG 2. US BNP And NTproBNP market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US BNP And NTproBNP market, key trends 2023
FIG 5. US BNP And NTproBNP market, growth prospects 2022-2032
FIG 6. US BNP And NTproBNP market, porters 5 force model
FIG 7. US BNP And NTproBNP market, pestel analysis
FIG 8. US BNP And NTproBNP market, value chain analysis
FIG 9. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 10. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 11. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 12. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 13. US BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
FIG 14. US BNP And NTproBNP market, company market share analysis (2023)
